These genes include genes involved in both cognitive function and glucose metabolism that previous studies have suggested may increase the risk of T2DM in schizophrenia patients and vice versa, including the AKT signaling pathway, which plays a key role in insulin metabolism in the liver.12 The gene discussed is INS; the disease is schizophrenia.